Thursday, 16 November 2017

FDA expands approval for Pfizer cancer drug Sutent

(Reuters) - The U.S. Food and Drug Administration on Thursday approved the use of Pfizer Inc's cancer drug Sutent to help prevent kidney cancer from returning following surgical removal of a kidney.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)